Network origin in George Chiu Uy first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to George Chiu Uy via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| HANDOK INC. | Pharmaceuticals: Other | Chief Executive Officer | |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
| NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
| COMPASS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Tufts University | College/University | Undergraduate Degree | |
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Hoechst Marion Roussel, Inc. | Chief Executive Officer | ||
| GENEXINE, INC. | Biotechnology | Chairman | |
| Korean German Chamber of Commerce & Industry | Director/Board Member | ||
| Korean German Society | President | ||
| Korea Pharmaceutical Manufacturers Association | Director/Board Member | ||
| Korea Hoechst Marion Roussel | Chief Executive Officer | ||
| Handok Jeseok Foundation | President | ||
The Korea Chamber of Commerce & Industry
 The Korea Chamber of Commerce & Industry Miscellaneous Commercial ServicesCommercial Services The Korea Chamber of Commerce & Industry (KCCI) is a business organization that provides resources, publications, events, and networks for its members. The organization is based in Seoul, North Korea and has overseas offices. The KCCI advocates for its members and partners with other organizations to promote bilateral economic cooperation. The KCCI also provides economic data and policy issues publications and hosts business forums and roundtables. Recently, the KCCI hosted a successful business forum with over 600 attendees, including political and business leaders from both countries. The Financial Services Commission identified five bank holding companies and five banks as domestic systemically important banks for 2024, and those identified as D-SIBs are required to set aside an additional common equity capital of 1.0, and the higher loss absorbency requirement will take effect on January 1, 2024. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Sanofi-Aventis Korea Co., Ltd.
 Sanofi-Aventis Korea Co., Ltd. Pharmaceuticals: MajorHealth Technology Sanofi-Aventis Korea Co., Ltd. provides pharmaceutical research and development services. Its products include prescription medicine, consumer health care, vaccines, and non-prescription medicine. The company founded in April 1991 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Chief Executive Officer | |
pH Pharma Co., Ltd.
 pH Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology pH Pharma Co. Ltd. engages in the developing and manufacturing of bio-pharmaceuticals. Its products include php-303, php-201, ab-101, nuvesse, alpine and torpedo products. The company was founded by Ho Young Huh on September 22, 2015 and is headquartered in Seoul, South Korea. | Pharmaceuticals: Major | Director/Board Member | |
| Kelley School of Business | College/University | Masters Business Admin | |
| REZOLUTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ROYALTY PHARMA PLC | Pharmaceuticals: Major | Chief Investment Officer |
Statistics
International
| United States | 13 |
| South Korea | 9 |
| Israel | 4 |
| Germany | 3 |
Sectoral
| Health Technology | 12 |
| Commercial Services | 4 |
| Consumer Services | 4 |
| Process Industries | 3 |
| Finance | 2 |
Operational
| Director/Board Member | 12 |
| Corporate Officer/Principal | 6 |
| Chief Executive Officer | 5 |
| Independent Dir/Board Member | 4 |
| Chairman | 3 |
Most connected contacts
| Insiders | |
|---|---|
| Young-Jin Kim | 15 |
| Miranda Toledano | 13 |
- Stock Market
- Insiders
- George Chiu Uy
- Company connections
